Media Summary: Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, discuss how the In this segment, Erik Dubberke, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo ... Dr. Mercurio, an ID Clinical Pharmacy Specialist at the James A Haley Veterans Hospital, presents an update on
Cost Benefit Analysis For C Difficile Infection Therapies - Detailed Analysis & Overview
Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, discuss how the In this segment, Erik Dubberke, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo ... Dr. Mercurio, an ID Clinical Pharmacy Specialist at the James A Haley Veterans Hospital, presents an update on On this episode, we review the 2021 Focused Update Guidelines on Management of Clostridioides Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, highlight Dale Gerding, MD, highlights the newest and most promising
Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, remark on recommendations for initiating ... Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, consider a role for initiating empiric Dale N. Gerding, MD; Yoav Golan, MD; and Peter Salgo, MD, remark on recent updates to guidelines for the management of ... Robin L. P. Jump, MD, PhD, Geriatric Research, Education and Clinical Center (GRECC), Louis Stokes Cleveland VA Medical ... Mercy Medical Center's Dr. Anurag Masheshwari explains what to watch for when it comes to recurring New guidelines contain some significant changes in the pharmacologic management of initial and recurrent CDI.
The latest innovation in treating the hard-to-treat
